Blesl, A; Binder, L; Hogenauer, C; Wenzl, H; Borenich, A; Pregartner, G; Berghold, A; Mestel, S; Kump, P; Baumann-Durchschein, F; Petritsch, W
Treatment persistence of first-line anti-TNF therapy in patients with inflammatory bowel diseases: results from a real-world study over 20 years
J CROHNS COLITIS. 2021; 15: S427-S428.
Doi: 10.1093/ecco-jcc/jjab076.548
[Poster]
Web of Science
FullText
FullText_MUG
Blesl, A; Rainer, F; Wurm, P; Durdevic, M; Petritsch, W; Wenzl, H; Baumann-Durchschein, F; Posch, A; Streit, A; Gorkiewicz, G; Grochenig, HP; Kump, P; Hogenauer, C
Predictors of non-response to repeated faecal microbiota transplantation in patients with therapy refractory ulcerative colitis
J CROHNS COLITIS. 2019; 13: S412-S412.
Doi: 10.1093/ecco-jcc/jjy222.718
Web of Science
FullText
FullText_MUG
Novacek, G; Tonko, S; Sobala, A; Tilg, H; Petritsch, W; Reinisch, W; Mayer, A; Haas, T; Ludwiczek, O; Feichtenschlager, T; Fuchssteiner, H; Steiner, P; Vogelsang, H; Miehsler, W; Platzer, R; Tillinger, W; Schmid, A; Blaha, B; Herkner, H
Does anticoagulation treatment increase the rate of major bleeding complications in patients with IBD and venous thromboembolism?
J CROHNS COLITIS. 2018; 12: S462-S463.
[Poster]
Web of Science
Blesl A, Rainer F, Kump P, Durchschein F, Wenzl H, Petritsch W, Eller K, Krisper P, Högenauer C
Erfolgreiche Therapie der sekundären Amyloidose mit Nierenbeteiligung mittels kombinierter Immun-
suppression bei zwei Patientinnen mit Morbus Crohn
; 2016.
[Poster]
Gombotz, E; Leitner, E; Zollner-Schwetz, I; Krause, R; Kornschober, C; Wenzl, H; Kump, P; Petritsch, W; Hogenauer, C
Infections with C. difficile in inflammatory bowel disease patients are difficult to treat and frequently recur
J CROHNS COLITIS. 2016; 10: S484-S485.-11th Congress of ECCO; March 16-19, 2016; Amsterdam, Netherlands.
[Poster]
Web of Science
Petritsch, W.
"Predictors of Response" zu verschiedenen Therapiestrategien
CED im Blickpunkt 2016; Dez 2-3, 2016; Berlin; GERMANY. 2016.
[Oral Communication]
Petritsch, W.
Ballondilatation: Was ist zu beachten?
Osterreichisches Crohn Colitis Symposium; SEP 30 - Okt 1, 2016; St. Wolfgang am Wolfgangsee. 2016.
[Oral Communication]
Petritsch W.
Komplikationsmanagement bei CED
49. Jahrestagung & 27. Fortbildungskurs der ÖGGH; JUN 16-18, 2016; Vienna, AUSTRIA. 2016.
[Oral Communication]
FullText
PK Kump, P Wurm, HP Gröchenig, HH Wenzl, w Petritsch, B Halwachs, M wagner, V. Stadlbauer-Köllner, AJ Eherer, KM Hoffmann, A Deutschmann, G Reicht, L Reiter, P Slawitsch, G Gorkiewicz, C Högenauer
Clinical Response to fecal microbiota Transplantation in chronic active ulcerative colitis depends on the taxonomic composition of the donor microbiota.
United European Gastroenterology Journal; 2016:2 (Supplement 1) . 2016; 2: -UEG week; 15.-19.10.2016; Wien.
[Oral Communication]
Frank, J; Hogenauer, C; Grochenig, HP; Hoffmann, KM; Reicht, G; Wenzl, HH; Petritsch, W; Kump, PK
Safety of fecal microbiota transplantation in patients with chronic colitis and immunosuppressive treatement.
J CROHNS COLITIS. 2015; 9: S245-S246.
[Poster]
Web of Science
J. Frank, C. Högenauer , H.P. Gröchenig, C.M. Hoffmann, G Reicht, H.H. Wenzl, W. Petritsch, P. Kump
Sicherheit der fäkalen Mikrobiota Transplantation (FMT) bei immunsupprimierten Patienten
48. Jahrestagung & 26. Fortbildungskurs der ÖGGH; JUN 18-20, 2015; Salzburg, AUSTRIA. 2015.
[Poster]
P. K. Kump, P. Wurm, H.-P. Gröchenig, L. Reiter, K. M. Hoffmann, W. Spindelboeck, G. Reicht, H. Wenzl, W.Petritsch, G. Gorkiewicz, C. Hoegenauer
Impact of Antibiotic Treatment Before Faecal Microbiota Transplantation (FMT) in Chronic Active Ulcerative Colitis
UEG 15-ABS-4930. 2015; -23rd United European Gastroenterology Week; OCT 24-28, 2015; Barcelona, SPAIN.
[Poster]
Petritsch, W;
Wie erkenne ich als CED-Patient ob ich richtig behandelt wurde?
ÖMCCV UPDATE XIII – Chronisch entzündliche Darmerkrankungen und Hepatologie; MAR 21, 2015; Leoben, AUSTRIA. 2015.
[Oral Communication]
Petritsch, W;
Eisenmangel bei gastroenterologischen Erkrankungen
Fortbildung am LKH Hartberg; NOV 2015; Hartberg, AUSTRIA. 2015.
[Oral Communication]
Petritsch, W;
Pouchitis, Antibiotika und Aus oder doch mehr?
CED- und Biologika Circle SÜD Interaktive Fortbildungsmöglichkeit der österr. Arbeitsgruppe für CED; MAY 8-9, 2015; Velden, AUSTRIA. 2015.
[Oral Communication]
Petritsch, W;
Steuerung der Anti-TNF-Therapie über Spiegelbestimmung
CED Symposium 2015; SEP 2015; Frankfurt, GERMANY. 2015.
[Oral Communication]
Petritsch, W;
Steuerung der Anti-TNF-Therapie über Spiegelbestimmung
Falk Symposium XXX; SEP 2015; Frankfurt, GERMANY. 2015.
[Oral Communication]
Zöhrer, E; Kelz, F; Petritsch, W; Högenauer, C; Wenzl, H; Jahnel, J
Loss of Response to Infliximab or Adalimumab is Associated with Levels of Drug and Antidrug Antibodies in IBD patients
-. 2015; -30.Jahrestagung der GPGE ; APR 23-25, 2015; Berlin, Austria.
[Oral Communication]
Zöhrer, E; Kelz, F; Petritsch, W; Högenauer, C; Wenzl, H; Jahnel, J
Prevention of loss of Response to TNF-A Blockers in Paediatric and Adult IBD patients by using the Graz Algorithm
-. 2015; -UEG (United European Gastroenterology) Week 2015; OCT 24-28, 2015; Barcelona, Spanien.
[Poster]
Wenzl, HH; Primas, C; Novacek, G; Teml, A; Öfferlbauer-Ernst,
A; Högenauer, C; Vogelsang, H; Petritsch, W; Reinisch, W
Absetzen von Azathioprin bei Patienten mit Mb. Crohn in
stabiler klinischer Remission: Eine placebokontrollierte
Doppelblindstudie über 2 Jahre
47. Jahrestagung & 25. Fortbildungskurs der ÖGGH; Jun 12-14, 2014; Villach, AUSTRIA. 2014.
[Poster]
FullText
Kump, PK; Gröchenig, HP; Spindelböck, W; Hoffmann, CM; Gorkiewicz, G; Wenzl, HH; Petritsch, W; Reicht, G; Hoegenauer, C
Klinischer Effekt wiederholt durchgeführte fäkale Mikrobiota Transplantation (Stuhltransplantation) bei chronisch aktiver therapierefraktärer Colitis Ulzerosa
ÖGGH Jahrestagung; Jun 13-15, 2013; Graz, AUStria. 2013.
[Poster]
Masser, T; Krones, E; Högenauer, C; Wenzl, HH; Stauber, R; Putz-Bankuti, C; Fickert, P; Zollner, G; Durchschein, F; Stadlbauer-Köllner, V; Spindelböck, W; Petritsch, P; Kump, P
Appendektomie und klinischer Verlauf bei Patienten mit Colitis ulcerosa
ÖGGH Jahrestagung; JUN 13-15, 2013; Graz, AUSTRIA. 2013.
[Poster]
Kump, PK; Grochenig, HP; Hoffmann, KM; Gorkiewicz, G; Lackner, S; Wenzl, HH; Petritsch, W; Reicht, G; Trajanoski, S; Hogenauer, C
Fecal Bacteria Therapy (Chair Transplantation) in refractory Ulcerative Colitis - a Pilot study.
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):570-570.
[Oral Communication]
Web of Science
Kump, P; Hogenauer, C; Wenzl, H; Hinterleitner, T; Petritsch, W
Opportunistic skin infections with Mycobacterium marinum under adalimumab therapy in a patient with Crohn's disease - a case report.
WIEN KLIN WOCHENSCHR. 2010; 122(17-18): A14-A14.
Web of Science
Ivastinovic, D; Högenauer, Chr; Petritsch, W; Wenzl, HH; Hinterleitner, Th
Efficacy of 6-thioguanine in patients with Crohn's disease intolerant to azathioprine
Gastroenterology2004; 126(4):630-631.-Digestive Disease Week; MAY 15-20, 2004 ; New Orleans, USA.
[Poster]
Hauer, AC; Deutsch, J; Goriup, U; Eherer, A; Weber-Mzell, D; Lanner, N; Erwa, W; Petritsch, W; Lanzer, G; Hartmann, M
Prävalenz der Zöliakie in Österreich.
Acta medica2003; Sonderheft (1):10-11.-Österreichische Gesellschaft für Allergologie und Immunologie; DEZ 4-6, 2003; Salzburg, AUSTRIA.
[Poster]
Hauer AC, Deutsch J, Goriup U, Eherer A, Weber-Mzell D, Lanner N, Erwa W, Petritsch W, Lanzer G, Hartmann M
Prävalenz der Zöliakie in Österreich
41. Jahrestagung der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde; OKT 1-4, 2003; Salzburg, AUSTRIA. 2003.
[Oral Communication]
Wenzl, HH; Jahnel, J; Hoegenauer, C; Hinterleitner, TA; Petritsch, W
Inadequately low antibodies against the tick-borne encephalitis virus in immunized patients with inflammatory bowel disease and azathioprine treatment
GASTROENTEROLOGY. 2003; 124(4): A205-A205.
Doi: 10.1016/S0016-5085(03)81029-6
Web of Science
FullText
FullText_MUG
Wenzl, HH; Hinterleitner, TA; Fickert, P; Aichbichler, BW; Metzler, O; Derler, AM; Petritsch, W
Low efficacy of long-term treatment with mycophenolate mofetil in patients with Crohn's disease.
GASTROENTEROLOGY 2000 118: 4214-4214.
Doi: 10.1016/S0016-5085(00)85302-0
Web of Science
FullText
FullText_MUG
Schonekas, H; Ahrens, H; Pannewick, U; Ell, C; Koop, H; Petritsch, W; Klein, M; Fischer, R
Comparison of two doses of intravenous pantoprazole in peptic ulcer bleeding
GASTROENTEROLOGY 1999 116: A305-A305.
Web of Science
Hammer, J; Hammer, HF; Eherer, AJ; Petritsch, W; Holzer, P; Krejs, GJ
Intrajejunal capsaicin causes pain in the human jejunum.
GASTROENTEROLOGY 1998 114: A760-A761.
Doi: 10.1016/S0016-5085(98)83112-0
Web of Science
FullText
FullText_MUG
Petritsch, W
Cardiovascular involvement in IBD: manifestations and drug effects
In: Lembcke, B; Kruis, W; Sartor, RB editor(s).FALK SYMPOSIUM; SYSTEMIC MANIFESTATIONS OF IBD - THE PENDING CHALLENGE FOR SUBTLE DIAGNOSTIC AND TREATMENT; MAY 25-26, 1997; TITSEE, GERMANY. DORDRECHT: KLUWER ACADEMIC PUBL; 1998. p.114-120.
Fickert, P; Hinterleitner, TA; Aichbichler, B; Wenzl, HH; Petritsch, W
Mycophenolate mofetil in patients with Crohn's disease
GASTROENTEROLOGY 1997 112: A972-A972.
Web of Science
Hinterleitner, TA; Fickert, P; Pamperl, I; Lindschinger, M; Anderhuber, W; Stammberger, H; Petritsch, W
Percutaneous endoscopic gastrostomy prevents aspiration but has no effect on quality of life and physical activity in patients with radiation therapy for neck cancer
GASTROENTEROLOGY 1997 112: A879-A879.
Web of Science
Wenzl, HH; Petritsch, W; Aichbichler, B; Hinterleitner, TA; Krejs, GJ
Cyclosporine in severe steroid-refractory ulcerative colitis: Short-term efficacy and long-term results.
GASTROENTEROLOGY 1997 112: A1117-A1117.
Web of Science
Fickert, P; Ramschak, H; Kenner, L; Hoefler, G; Hinterleitner, TA; Petritsch, W; Klimpfinger, M; Krejs, GJ; Stauber, RE
Acute Budd Chiari syndrome with fulminant hepatic failure in a pregnant woman with factor V Leiden mutation.
HEPATOLOGY 1996 24: 1534-1534.
Web of Science
Petritsch, W; Aichbichler, B; Hinterleitner, T; Ranner, G; Kreis, GJ
Combination of cyclosporin, azathioprine and prednisolone for the treatment of fistulas in Crohn's disease.
GASTROENTEROLOGY 1996 110: A990-A990.
Web of Science
HITNERLEITNER, TA; EHERER, AJ; FICKERT, P; PETRITSCH, W; BEUBLER, E; FRIEDLAND, T; KREJS, GJ
SACCHAROMYCES-BOULARDII HAS NO EFFECT ON CHOLERA TOXIN-INDUCED WATER AND ELECTROLYTE SECRETION IN THE HUMAN JEJUNUM
GASTROENTEROLOGY 1995 108: A290-A290.
Web of Science
PETRITSCH, W; HINTERLEITNER, TA; AICHBICHLER, B; DENK, H; HAMMER, HF; KREJS, GJ
ENDOSONOGRAPHIC FINDINGS IN COLITIS CYSTICA PROFUNDA AND SOLITARY RECTAL ULCER SYNDROME
GASTROINTEST ENDOSCOP 1995 41: 383-383.
Doi: 10.1016/S0016-5107(05)80387-6
Web of Science
FullText
FullText_MUG
PETRITSCH, W; HINTERLEITNER, TA; BERARD, H; LECOMTE, JM; KREJS, GJ
ACETORPHAN INHIBITS CHOLERA TOXIN-INDUCED WATER AND ELECTROLYTE SECRETION IN THE HUMAN JEJUNUM
GASTROENTEROLOGY 1995 108: A668-A668.
Web of Science
STAUBER, RE; TRAUNER, MH; HAUSEGGER, K; PETRITSCH, W
IMPROVEMENT OF LIVER-FUNCTION AFTER TRANSJUGULAR INTRAHEPATIC PORTASYSTEMIC SHUNT (TIPS) IN A PATIENT WITH CHRONIC BUDD-CHIARI SYNDROME
HEPATOLOGY. 1993; 18(4): A344-A344.
Doi: 10.1016/0270-9139(93)92899-B
Web of Science
FullText
FullText_MUG
PRISTAUTZ, H; PETRITSCH, W; SCHREIBER, F; EBER, B; SOMMERSGUTTER, M; PFNISS, G; STAUBER, R
INVITRO MEASUREMENT OF THE PROTECTIVE EFFECT OF SUCRALFATE ON HUMAN GASTRIC-MUCOSA
Z GASTROENTEROL. 1987; 25(8): 538-538.
Web of Science